Measurement of α- synuclein as protein cargo in plasma extracellular vesicles

成果类型:
Article
署名作者:
Gilboa, Tal; Ter-Ovanesyan, Dmitry; Wang, Shih-Chin; Whiteman, Sara; Kannarkat, George T.; Church, George M.; Chen-Plotkin, Alice S.; Walt, David R.
署名单位:
Harvard University; Harvard University; Harvard University Medical Affiliates; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania
刊物名称:
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
ISSN/ISSBN:
0027-15104
DOI:
10.1073/pnas.2408949121
发表日期:
2024-11-05
关键词:
alzheimers-disease identification exosomes
摘要:
Extracellular vesicles (EVs) are released by all cells and hold great promise as a class of biomarkers. This promise has led to increased interest in measuring EV proteins from both total EVs as well as brain- derived EVs in plasma. However, measuring cargo proteins in EVs has been challenging because EVs are present at low levels, and EV isolation methods are imperfect at separating EVs from free proteins. Thus, knowing whether a protein measured after EV isolation is truly inside EVs is difficult. In this study, we developed methods to measure whether a protein is inside EVs and quantify the ratio of a protein in EVs relative to total plasma. To achieve this, we combined a high- yield size- exclusion chromatography protocol with an optimized protease protection assay and Single Molecule Array (Simoa) digital enzyme- linked immunoassays (ELISAs) for ultrasensitive measurement of proteins inside EVs. We applied these methods to analyze alpha- synuclein and confirmed that a small fraction of the total plasma alpha- synuclein is inside EVs. Additionally, we developed a highly sensitive Simoa assay for phosphorylated alpha- synuclein (phosphorylated at the Ser129 residue). We found enrichment in the phosphorylated alpha- synuclein to total alpha- synuclein ratio inside EVs relative to outside EVs. Finally, we applied the methods we developed to measure total and phosphorylated alpha- synuclein inside EVs from Parkinson's disease and Lewy body dementia patient samples. This work provides a framework for determining the levels of proteins in EVs and represents an important step in the development of EV diagnostics for diseases of the brain, as well as other organs.